Cargando…

Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions

Antibodies specific for neutralizing epitopes in either Human papillomavirus (HPV) capsid protein L1 or L2 can mediate protection from viral challenge and thus their accurate and sensitive measurement at high throughput is likely informative for monitoring response to prophylactic vaccination. Here...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Joshua W., Jagu, Subhashini, Wang, Chenguang, Kitchener, Henry C., Daayana, Sai, Stern, Peter L., Pang, Susana, Day, Patricia M., Huh, Warner K., Roden, Richard B. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084990/ https://www.ncbi.nlm.nih.gov/pubmed/24999962 http://dx.doi.org/10.1371/journal.pone.0101576

Ejemplares similares

Role of L2 cysteines in papillomavirus infection and neutralization
por: Gambhira, Ratish, et al.
Publicado: (2009)

Optimization of Multimeric Human Papillomavirus L2 Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2013)

Multivalent Human Papillomavirus L1 DNA Vaccination Utilizing Electroporation
por: Kwak, Kihyuck, et al.
Publicado: (2013)

Efficient Delivery of DNA Vaccines using Human Papillomavirus Pseudovirions
por: Peng, Shiwen, et al.
Publicado: (2010)

Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies
por: Combelas, Nicolas, et al.
Publicado: (2010)

Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
por: Daayana, S, et al.
Publicado: (2010)

Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
por: Kwak, Kihyuck, et al.
Publicado: (2014)

Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells
por: Lamprecht, Renate L, et al.
Publicado: (2016)

Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry
por: Hindmarsh, Patrick L, et al.
Publicado: (2007)

Capsomer Vaccines Protect Mice from Vaginal Challenge with Human Papillomavirus
por: Wu, Wai-Hong, et al.
Publicado: (2011)

Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants
por: Pietersen, Inge, et al.
Publicado: (2020)

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2009)

Ovarian Cancer Gene Therapy Using HPV-16 Pseudovirion Carrying the HSV-tk Gene
por: Hung, Chien-Fu, et al.
Publicado: (2012)

Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions
por: Schäfer, Georgia, et al.
Publicado: (2017)

Autophagy is induced in human keratinocytes during human papillomavirus 11 pseudovirion entry
por: Han, Rui, et al.
Publicado: (2020)

Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9
por: Oleaga, Carlota, et al.
Publicado: (2020)

Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method
por: Toh, Zheng Quan, et al.
Publicado: (2020)

Thiol-reactive reagents inhibits intracellular trafficking of human papillomavirus type 16 pseudovirions by binding to cysteine residues of major capsid protein L1
por: Ishii, Yoshiyuki, et al.
Publicado: (2007)

Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus
por: Nie, Jianhui, et al.
Publicado: (2016)

Sequential Cisplatin Therapy and Vaccination with HPV16 E6E7L2 Fusion Protein in Saponin Adjuvant GPI-0100 for the Treatment of a Model HPV16+ Cancer
por: Peng, Shiwen, et al.
Publicado: (2015)

Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes
por: Kalnin, Kirill, et al.
Publicado: (2017)

High-Throughput Pseudovirion-Based Neutralization Assay for Analysis of Natural and Vaccine-Induced Antibodies against Human Papillomaviruses
por: Sehr, Peter, et al.
Publicado: (2013)

Immunogenicity correlation in cynomolgus monkeys between Luminex‐based total IgG immunoassay and pseudovirion‐based neutralization assay for a 14‐valent recombinant human papillomavirus vaccine
por: Bei, Lei, et al.
Publicado: (2022)

Torso-like mediates extracellular accumulation of Furin-cleaved Trunk to pattern the Drosophila embryo termini
por: Johnson, Travis K., et al.
Publicado: (2015)

DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity
por: Peng, Shiwen, et al.
Publicado: (2011)

Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin
por: Susan-Resiga, Delia, et al.
Publicado: (2021)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

An Efficient Catalytic DNA that Cleaves L-RNA
por: Tram, Kha, et al.
Publicado: (2015)

Furin extracellularly cleaves secreted PTENα/β to generate C-terminal fragment with a tumor-suppressive role
por: Zhang, Cheng, et al.
Publicado: (2022)

Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels
por: Lipari, Michael T., et al.
Publicado: (2012)

Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach
por: Wu, Wai-Hong, et al.
Publicado: (2015)

Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects
por: Kataoka, Yu, et al.
Publicado: (2021)

Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection
por: Cruz, Linda, et al.
Publicado: (2015)

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
por: Peng, Shiwen, et al.
Publicado: (2021)

Accuracy of detection of high-grade cervical intraepithelial neoplasia using electrical impedance spectroscopy with colposcopy
por: Tidy, JA, et al.
Publicado: (2013)

Opportunities to improve immune-based prevention of HPV-associated cancers
por: Stern, Peter L., et al.
Publicado: (2019)

Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay
por: Zhou, Yanchen, et al.
Publicado: (2011)

Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System
por: Mahalingam, Gokulnath, et al.
Publicado: (2022)

Identification of an immunogenic epitope and protective antibody against the furin cleavage site of SARS-CoV-2
por: Li, Lili, et al.
Publicado: (2022)

Immunogenicity of a Trivalent Human Papillomavirus L1 DNA-Encapsidated, Non-Replicable Baculovirus Nanovaccine
por: Cho, Hansam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rc1dqj6ns8qhjli7qt90vlp3ju